Cargando…
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
Coronavirus disease-19 (Covid-19) pandemic have demonstrated the importantance of vaccines in disease prevention. Self-amplifying mRNA vaccines could be another option for disease prevention if demonstrated to be safe and immunogenic. Phase 1 of this randomized, double-blinded, placebo-controlled tr...
Autores principales: | Low, Jenny G., de Alwis, Ruklanthi, Chen, Shiwei, Kalimuddin, Shirin, Leong, Yan Shan, Mah, Tania Ken Lin, Yuen, Natalene, Tan, Hwee Cheng, Zhang, Summer L., Sim, Jean X. Y., Chan, Yvonne F. Z., Syenina, Ayesa, Yee, Jia Xin, Ong, Eugenia Z., Sekulovich, Rose, Sullivan, Brian B., Lindert, Kelly, Sullivan, Sean M., Chivukula, Pad, Hughes, Steven G., Ooi, Eng Eong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745278/ https://www.ncbi.nlm.nih.gov/pubmed/36513697 http://dx.doi.org/10.1038/s41541-022-00590-x |
Ejemplares similares
-
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
por: Ong, Eugenia Z., et al.
Publicado: (2022) -
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
por: Kalimuddin, Shirin, et al.
Publicado: (2021) -
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
por: de Alwis, Ruklanthi, et al.
Publicado: (2020) -
Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes
por: Syenina, Ayesa, et al.
Publicado: (2022) -
Minding the “T”s beyond the “B”s: Shaping vaccines for future pandemics
por: Kalimuddin, Shirin, et al.
Publicado: (2023)